The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines
Open accessAbstract
Background: Malaria caused by Plasmodium falciparum in pregnancy can result in adverse maternal and fetal sequelae. This review evaluated the adherence of the national guidelines drawn from World Health Organization (WHO) regions, Africa, Eastern Mediterranean, Southeast Asia, and Western Pacific, to the WHO recommendations on drug treatment and prevention of chloroquine-resistant falciparum malaria in pregnant women. Methods: Thirty-five updated national guidelines and the President’s Malaria Initiative (PMI), available in English language, were reviewed. The primary outcome measures were the first-line anti-malarial treatment protocols adopted by national guidelines for uncomplicated and complicated falciparum malaria infections in early (first) and late (second and third) trimesters of pregnancy. The strategy of intermittent preventive treatment of malaria in pregnancy (IPTp) with sulfadoxine-pyrimethamine (SP) was also addressed. Results: This review evaluated the treatment and prevention of falciparum malaria in pregnancy in 35 national guidelines/PMI-Malaria Operational Plans (MOP) reports out of 95 malaria-endemic countries. Of the 35 national guidelines, 10 (28.6%) recommend oral quinine plus clindamycin as first-line treatment for uncomplicated malaria in the first trimester. As the first-line option, artemether–lumefantrine, an artemisinin-based combination therapy, is adopted by 26 (74.3%) of the guidelines for treating uncomplicated or complicated malaria in the second and third trimesters. Intravenous artesunate is approved by 18 (51.4%) and 31 (88.6%) guidelines for treating complicated malaria during early and late pregnancy, respectively. Of the 23 national guidelines that recommend IPTp-SP strategy, 8 (34.8%) are not explicit about directly observed therapy requirements, and three-quarters, 17 (73.9%), do not specify contra-indication of SP in human immunodeficiency virus (HIV)-infected pregnant women receiving cotrimoxazole prophylaxis. Most of the guidelines (18/23; 78.3%) state the recommended folic acid dose. Conclusion: Several national guidelines and PMI reports require update revisions to harmonize with international guidelines and emergent trends in managing falciparum malaria in pregnancy. National guidelines and those of donor agencies should comply with those of WHO guideline recommendations although local conditions and delayed guideline updates may call for deviations from WHO evidence-based guidelines.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Malaria in pregnancy can be particularly severe, and artesunate has become the treatment of choice for all trimesters [130, 131].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These measures include IPTp-SP, the use of ITNs and the use of IRS in conjunction with nutritional interventions [130, 160, 181, 194].”
From Current update on malaria in pregnancy: a systematic review (2025) · cites this paper as [130]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quinine, an old anti-malarial drug in a modern world: role in the treatment of malaria
Achan, J., Talisuna, A. O., Erhart, A., Yeka, A., Tibenderana, J. K., Baliraine, F. N., Rosenthal, P. J., & D'Alessandro, U. (2011) · Malaria Journal · doi:10.1186/1475-2875-10-144 · Cited by 1,007
McGregor, I. A., Wilson, M. E., & Billewicz, W. Z. (1983) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(83)90081-0 · Cited by 393
Malaria during pregnancy in an area of unstable endemicity.
Nosten, F., ter Kuile, F., Maelankirri, L., Decludt, B., & White, N. J. (1991) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1016/0035-9203(91)90205-d · Cited by 294
van der Pluijm, R. W., Tripura, R., Hoglund, R. M., Pyae Phyo, A., Lek, D., ul Islam, A., Anvikar, A. R., Satpathi, P., Satpathi, S., Behera, P. K., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30552-3 · Cited by 271
Verhoeff, F. H., Brabin, B. J., Hart, C. A., Chimsuku, L., Kazembe, P., & Broadhead, R. L. (1999) · Tropical Medicine & International Health · doi:10.1046/j.1365-3156.1999.00349.x · Cited by 236
McGready, R., Lee, S., Wiladphaingern, J., Ashley, E., Rijken, M., Boel, M., Simpson, J., Paw, M., Pimanpanarak, M., Mu, O., et al. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70339-5 · Cited by 228
Desai, M., Gutman, J., L'lanziva, A., Otieno, K., Juma, E., Kariuki, S., Ouma, P., Were, V., Laserson, K., Katana, A., et al. (2015) · The Lancet · doi:10.1016/s0140-6736(15)00310-4 · Cited by 198
Malaria in pregnancy in the Asia-Pacific region
Rijken, M. J., McGready, R., Boel, M. E., Poespoprodjo, R., Singh, N., Syafruddin, D., Rogerson, S., & Nosten, F. (2012) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(11)70315-2 · Cited by 181
Pukrittayakamee, S., Chotivanich, K., Chantra, A., Clemens, R. L., Looareesuwan, S., & White, N. J. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.4.1329-1334.2004 · Cited by 178
Peters, P. J., Thigpen, M. C., Parise, M. E., & Newman, R. D. (2007) · Drug Safety · doi:10.2165/00002018-200730060-00003 · Cited by 174
Research works printed but not linked: 2
- WHO. Guidelines for the treatment of malaria, 2nd Edn. Geneva, World Health Organization, 2010. https://www.ncbi.nlm.nih.gov/books/NBK254223/. Accessed 5 Jun 2020.
- Management Sciences for Health (MSH)/WHO. International Medical Products Price Guide. 2015 edition. https://www.msh.org/sites/default/files/msh-2015-international-medical-products-price-guide.pdf. Accessed 7 Jun 2020.
Cited by
Armando, C. J., Rocklöv, J., Sidat, M., Tozan, Y., Mavume, A. F., Bunker, A., & Sewe, M. O. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1162535 · Cited by 63
Current update on malaria in pregnancy: a systematic review
Minwuyelet, A., Yewhalaw, D., Siferih, M., & Atenafu, G. (2025) · Tropical Diseases, Travel Medicine and Vaccines · doi:10.1186/s40794-025-00248-1 · Cited by 49
Kalu, F. A., & Chukwurah, J. N. (2022) · BMC Pregnancy and Childbirth · doi:10.1186/s12884-022-04804-x · Cited by 30
“Studies have found that (prophylactic) treatment for malaria in countries with moderate to high prevalence of malaria helps to inhibit or minimize the effects of malarial parasites on the red blood cells, thus reducing the risks of maternal anaemia, placental malaria, preterm birth and pregnancy loss [1, 38, 39].”
BackgroundRe-orienting anti-malarial drug development to better serve pregnant women
Gaaloul, M. E., Tornesi, B. M., Lebus, F., Reddy, D., & Kaszubska, W. (2022) · Malaria Journal · doi:10.1186/s12936-022-04137-2 · Cited by 24
Adams, L., Afiadenyo, M., Kwofie, S. K., Wilson, M. D., Kusi, K. A., Obiri‐Yeboah, D., Moane, S., & McKeon‐Bennett, M. (2023) · Phytomedicine Plus · doi:10.1016/j.phyplu.2023.100447 · Cited by 27
Metadata
- Authors
- Al Khaja, K. A. J., & Sequeira, R. P.
- Affiliations
- Arabian Gulf University (BH)
- Venue
- Malaria Journal
- Published
- 2021-01-23
- Volume
- 20
- Issue
- 1
- Pages
- 62-62
- ISSN
- 1475-2875 (ISSN-L)
- PMC
- PMC7825227
- OpenAlex
- W3121915585
- Cited by
- 39
- References
- 54
- Citations by year
- 2026: 1 · 2025: 10 · 2024: 12 · 2023: 7 · 2022: 6 · 2021: 3
- FWCI
- 1.25
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Malaria Journal (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Travel-related health issues
- Keywords
- malaria in pregnancy, Plasmodium falciparum, chloroquine resistance, national treatment guidelines, WHO guidelines, artemether-lumefantrine, artesunate, sulfadoxine-pyrimethamine, intermittent preventive treatment, quinine, HIV coinfection, folic acid supplementation, guideline adherence, President's Malaria Initiative, malaria prevention in pregnancy
- MeSH terms
- Artesunate, Artemether, Artemether, Lumefantrine Drug Combination, Adult, Antimalarials, Chloroquine, Drug Combinations, Female, Humans, Malaria, Pregnancy, Pyrimethamine, Quinine, Sulfadoxine, Pregnancy Complications, Parasitic, Practice Guidelines as Topic, Parasitemia
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines. https://app.cochat.ai/papers/10.1186/s12936-020-03565-2
- The paper
- Al Khaja, K. A. J., & Sequeira, R. P. (2021). Drug treatment and prevention of malaria in pregnancy: a critical review of the guidelines. Malaria Journal. https://doi.org/10.1186/s12936-020-03565-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.